We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

AusPAR: Jubbonti/Wyost

Australian Public Assessment Report

AusPAR

AusPAR: Jubbonti/Wyost [PDF, 423.67 KB]

AusPAR: Jubbonti/Wyost [Word, 395.72 KB]

Attachment: Product information for Jubbonti [PDF, 339.76 KB]

Attachment: Product information for Jubbonti [Word, 199.19 KB]

Attachment: Product information for Wyost [PDF, 498.84 KB]

Attachment: Product information for Wyost [Word, 591.8 KB]

Device/Product Name

Jubbonti/Wyost

Active ingredients

Denosumab

AusPAR Date

10 October 2024

Published

28 October 2024

Submission Number

PM-2023-03741-1-5

Submission Type

New biological entity (Biosimilar)

Decision

Approved